Yi-Heng Huang, Xin-Lu Guo, Meng-Ke Shan, Gui-Wen Yang, Hui-Ting Yang
{"title":"Class B scavenger receptor resists WSSV replication by recognizing the viral lipid molecule and promoting phagocytosis.","authors":"Yi-Heng Huang, Xin-Lu Guo, Meng-Ke Shan, Gui-Wen Yang, Hui-Ting Yang","doi":"10.1128/jvi.01700-24","DOIUrl":null,"url":null,"abstract":"<p><p>Class B scavenger receptors (SRBs) have been well-studied in bacteria-induced immune responses in invertebrates. However, the status of SRB-defending viruses remains unclear. In this study, we identified a scavenger receptor in <i>Procambarus clarkii</i> (crayfish), which is homologous to mammalian SRBs, and designated it as <i>Pc</i>SRB. The expression of <i>Pc</i>SRB was upregulated after the WSSV challenge. The survival rate of crayfish was decreased, but the WSSV copy number increased after <i>Pc</i>SRB knockdown during virus invasion. In addition, <i>Pc</i>SRB bound to WSSV. Furthermore, we detected how <i>Pc</i>SRB interacted with WSSV, and we found that <i>Pc</i>SRB could bind to cholesta-3,5-diene, (CD3,5), a novel WSSV lipid ligand, rather than dibutyl phthalate (DBP). Besides, <i>Pc</i>SRB could bind to VP19, VP26, and VP28, rather than VP24. Mutant-binding experiments demonstrated that the hydrophobic domain (130-180 aa) of <i>Pc</i>SRB is important for recognizing WSSV. Furthermore, <i>Pc</i>SRB might promote lysosomal eliminating function to degrade WSSV. Altogether, we identified a new mechanism for scavenger receptor recognition and resistance to WSSV.IMPORTANCE<i>Pc</i>SRB could bind to WSSV directly. <i>Pc</i>SRB could interact with WSSV via binding to lipid molecule CD3,5 and viral envelope proteins. <i>Pc</i>SRB could influence lysosomal activation.</p>","PeriodicalId":17583,"journal":{"name":"Journal of Virology","volume":" ","pages":"e0170024"},"PeriodicalIF":4.0000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/jvi.01700-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Class B scavenger receptors (SRBs) have been well-studied in bacteria-induced immune responses in invertebrates. However, the status of SRB-defending viruses remains unclear. In this study, we identified a scavenger receptor in Procambarus clarkii (crayfish), which is homologous to mammalian SRBs, and designated it as PcSRB. The expression of PcSRB was upregulated after the WSSV challenge. The survival rate of crayfish was decreased, but the WSSV copy number increased after PcSRB knockdown during virus invasion. In addition, PcSRB bound to WSSV. Furthermore, we detected how PcSRB interacted with WSSV, and we found that PcSRB could bind to cholesta-3,5-diene, (CD3,5), a novel WSSV lipid ligand, rather than dibutyl phthalate (DBP). Besides, PcSRB could bind to VP19, VP26, and VP28, rather than VP24. Mutant-binding experiments demonstrated that the hydrophobic domain (130-180 aa) of PcSRB is important for recognizing WSSV. Furthermore, PcSRB might promote lysosomal eliminating function to degrade WSSV. Altogether, we identified a new mechanism for scavenger receptor recognition and resistance to WSSV.IMPORTANCEPcSRB could bind to WSSV directly. PcSRB could interact with WSSV via binding to lipid molecule CD3,5 and viral envelope proteins. PcSRB could influence lysosomal activation.
期刊介绍:
Journal of Virology (JVI) explores the nature of the viruses of animals, archaea, bacteria, fungi, plants, and protozoa. We welcome papers on virion structure and assembly, viral genome replication and regulation of gene expression, genetic diversity and evolution, virus-cell interactions, cellular responses to infection, transformation and oncogenesis, gene delivery, viral pathogenesis and immunity, and vaccines and antiviral agents.